Legend Biotech to Host Investor Conference Call on Third Quarter 2024 Results
24 Octobre 2024 - 2:00PM
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a
global leader in cell therapy, will host a conference call for
investors at 8:00 am ET on Tuesday, November 12, 2024, to review
third-quarter 2024 results.
During the webcast and conference call, senior leaders will
provide an overview of Legend Biotech’s performance for the
quarter.
Investors and other interested parties may join the live audio
webcast of the call via this weblink.
A replay version of the webcast and earnings news release will
be available through the Investor Relations section of Legend
Biotech’s website under the Events and Presentation section
approximately two hours after the call concludes.
ABOUT LEGEND BIOTECH
Legend Biotech is a global biotechnology
company dedicated to treating, and one day curing, life-threatening
diseases. Headquartered in Somerset, New Jersey, we are
developing advanced cell therapies across a diverse array of
technology platforms, including autologous and allogeneic chimeric
antigen receptor T-cell, gamma-delta T cell (gd T) and natural
killer (NK) cell-based immunotherapy. From our three R&D sites
around the world, we apply these innovative technologies to pursue
the discovery of cutting-edge therapeutics for patients
worldwide.
Learn more
at www.legendbiotech.com and follow us on X
(formerly Twitter) and LinkedIn.
INVESTOR CONTACT:
Jessie YeungTel: (732) 956-8271
jessie.yeung@legendbiotech.com
PRESS CONTACT:Mary Ann
OndishTel: (914) 552-4625media@legendbiotech.com
Legend Biotech (NASDAQ:LEGN)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024
Legend Biotech (NASDAQ:LEGN)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024